Telesis Bio falls after revenue miss
** Shares of Telesis Bio Inc TBIO.O down 15.6% at $2.4
** Co reports Q1 revenue of $6.3 mln, missing Wall Street
estimates of $7.4 mln, according to Refinitiv
** Also reports Q1 net loss per share of $0.37, in line with
Refinitiv estimates
** Co's cash and cash equivalents $32.2 mln as of March 31,
compared with $43.8 mln as of Dec. 31
** TBIO shares up 140% YTD
(Reporting by Tanya Jain)
((Tanya.Jain@thomsonreuters.com))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview